Segments - Extracorporeal Shock Wave Lithotripsy Market by Technology (Electrohydraulic, Electromagnetic and Piezoelectric), Application (Pancreatic Stone, Biliary Calculi, Salivary Stone, Kidney Stone, and Others), End-user (Hospital, Clinic, Radiology Labs, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2024–2032
The global extracorporeal shock wave lithotripsy market size was USD 1.33 Billion in 2023 and is projected to reach USD 2.1 Billion by 2032, expanding at a CAGR of 5.2% during 2024–2032. The market growth is attributed to the increasing demand for minimally invasive procedures and technological advancements in lithotripsy technology across the globe.
Growing consumer base seeking effective solutions for kidney stone management is boosting the extracorporeal shock wave lithotripsy market. Non-invasive nature and minimal postoperative complications make this lithotripsy an attractive option for patients and healthcare providers. Moreover, the high prevalence of obesity and metabolic disorders facilitating the increased risk of kidney stone formation further propels the widespread adoption of extracorporeal shock wave lithotripsy.
According to a report published by WHO on March 1, 2024, in 2022, 2.5 billion adults aged 18 years and above were overweight.
The use of artificial intelligence is likely to boost the extracorporeal shock wave lithotripsy market. AI-powered software generates personalized treatment plans tailored to individual anatomies and stone characteristics. Additionally, AI-driven image processing techniques enable precise targeting of stones for enhancing patient safety.
Increasing prevalence of kidney stones globally is expected to drive the market during the forecast period. Unhealthy dietary habits, sedentary lifestyles, and inadequate hydration are causing incidences of kidney stones. For instance, according to a report published by the National Library of Medicine on February 2, 2023, the prevalence of kidney stones was high among overweight (9.2%) and obese individuals (11.2%) between 2007 and 2010. Furthermore, the rising preference for outpatient procedures and the associated cost-effectiveness are projected to boost the market in the coming years.
Alternative treatment modalities for kidney stones are expected to hinder the market in the coming years. Healthcare is utilizing alternative treatments such as ureteroscopy with laser lithotripsy and percutaneous nephrolithotomy (PCNL) for their improved stone clearance rates the treatment outcomes. Moreover, the limited availability of reimbursement policies for lithotripsy procedures further hampers the market.
Ongoing research and advancement activities in the field of extracorporeal shock wave lithotripsy are expected to create immense opportunities for the players competing in the market during the forecast period. Manufacturers are focusing on improving shock wave generation, focusing techniques, and imaging integration are poised to enhance treatment efficacy and patient outcomes. Moreover, the growing patient preference for non-invasive treatment options further boosts the market.
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics are included in the report.
Attributes |
Details |
Report Title |
Extracorporeal Shock Wave Lithotripsy Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2023 |
Historic Data |
2017 -2022 |
Forecast Period |
2024–2032 |
Segmentation |
Technology (Electrohydraulic, Electromagnetic, and Piezoelectric), Application (Pancreatic Stone, Biliary Calculi, Salivary Stone, Kidney Stone, and Others), and End-user (Hospital, Clinic, Radiology Labs, and Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
Key Players Covered in the Report |
Applaud Medical, Inc; Cook; Dornier MedTech; MTS Medical; Olympus Corporation; and Richard Wolf GmbH |
Based on technology, the extracorporeal shock wave lithotripsy market is divided into electrohydraulic, electromagnetic, and piezoelectric. The piezoelectric segment held the major share of the market in 2023, as they offer superior performance characteristics as compared to other lithotripsy modalities.
Piezoelectric lithotripters provide high shock wave focal depths and energy control, enabling efficient fragmentation of kidney stones while minimizing the risk of collateral tissue injury. Additionally, the advancements in piezoelectric lithotripter designs, such as dual-focus and multifunctional systems, have further fueled the segment.
The electromagnetic technology segment is expected to expand at a significant growth rate in the coming years, owing to its enhanced shock wave penetration and improved treatment depths. Electromagnetic lithotripter designs incorporating advanced imaging modalities and precise shock wave targeting help in kidney stone treatment by providing personalized and optimized treatment approaches. Moreover, a growing demand for minimally invasive lithotripsy procedures and the expanding use of electromagnetic lithotripters in outpatient settings.
On the basis of application, the global market is segregated into pancreatic stone, biliary calculi, salivary stone, kidney stone, and others. The kidney stone segment held largest market share in 2023, due to the high incidence of kidney stone formation. Additionally, the non-invasive nature of ESWL further boosts their utilization in kidney stone treatment, thereby boosting the market.
The biliary calculi segment is anticipated to expand at a substantial CAGR during the forecast period, owing to the growing trend towards using lithotripsy to treat this type of disease. Moreover, the rising prevalence of risk factors, such as obesity and metabolic syndrome is expected to fuel the demand for lithotripsy procedures targeting biliary calculi.
Based on end-user, the extracorporeal shock wave lithotripsy market is segmented into subsegments. The clinic segment is projected to register a robust growth rate during the assessment years. Clinics offer outpatient lithotripsy services in community-based settings, catering to the growing demand for convenient and accessible healthcare solutions. Additionally, the rising trend towards ambulatory healthcare services and same-day surgical procedures further boosts the lithotripsy services in clinic settings.
In terms of region, the global extracorporeal shock wave lithotripsy market is classified as Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa. North America held a major market share in 2023, due to high healthcare expenditure and advanced healthcare infrastructure in the region.
Favorable reimbursement policies and strong patient awareness are facilitating the widespread adoption of extracorporeal shock wave lithotripsy (ESWL) procedures in this region. Moreover, the large patient pool with kidney stone-related conditions further boosts the market in this North America.
The market in Asia Pacific is projected to grow at a significant pace in the coming years, owing to the rising prevalence of kidney stones. Additionally, the increasing adoption of minimally invasive treatments and shifting patient preferences toward outpatient care are further propelling the demand for advanced lithotripsy solutions in this region.
The extracorporeal shock wave lithotripsy market has been segmented on the basis of
Key players competing in the global extracorporeal shock wave lithotripsy market are Applaud Medical, Inc; Cook; Dornier MedTech; MTS Medical; Olympus Corporation; and Richard Wolf GmbH
These companies use development strategies including mergers, acquisitions, partnerships, collaboration, and product launches to expand their consumer base worldwide.
On January 31, 2022, Applaud Medical, Inc, a key medical equipment manufacturer, announced the Food and Drug Administration (FDA) granted advanced device designation to the Acoustic Enhancer technology. This innovative technology is intended for use alongside ureteroscopy with laser lithotripsy (URS-LL) procedures specifically designed for breaking down calcium-based urinary stones.